Toddm Hobbs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Toddm hobbs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Toddm Hobbs Today - Breaking & Trending Today

Hepion Pharmaceuticals Completes Final Patient Recruitment in Phase 2a 'AMBITION' ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Hepion Pharmaceuticals Completes Final Patient Recruitment in Phase 2a ‘AMBITION’ .
Hepion Pharmaceuticals, Inc.May 6, 2021 GMT
EDISON, N.J., May 06, 2021 (GLOBE NEWSWIRE) Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”), today announced that it has completed recruitment for its Phase 2a ‘AMBITION’ clinical trial, with all NASH patients in the 225 mg CRV431 dosing cohort now enrolled.
“Over the past few months, the COVID-19 pandemic, compounded by the inclement weather experienced at some of our clinical trial sites in Texas, which resulted in power outages, presented difficulties in the recruitment of subjects for the second and final dosing cohort for our Phase 2a NASH trial,” said ....

United States , Stephen Kilmer , Toddm Hobbs , Robert Foster , Exchange Commission , Hepion Pharmaceuticals , Hepion Pharmaceuticals Investor Relations , Hepion Pharmaceuticals Inc , Chief Medical , Artificial Intelligence , Private Securities Litigation Reform Act , Hepion Pharmaceutical , Hepion Pharmaceutical Form , ஒன்றுபட்டது மாநிலங்களில் , ஸ்டீபன் கில்மர் , ராபர்ட் வளர்ப்பு , பரிமாற்றம் தரகு , தலைமை மருத்துவ , செயற்கை உளவுத்துறை , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

Former Novo Nordisk Executive, Dr. Todd M. Hobbs, Joins Hepion Pharmaceuticals as Chief Medical Officer

EDISON, NJ / ACCESSWIRE / February 10, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)("Hepion"), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis ("NASH") and liver disease, today announced the appointment of Todd M. ....

Helvetica Neue , Yahoo Holdings Inc , American Medical Group Association , Novo Nordisk , Toddm Hobbs , Hepion Pharmaceuticals , Clinical Development , Liver Disease , Artificial Intelligence , Drug Discovery , Clinical Stage , யாகூ ஹோல்டிங்ஸ் இன்க் , அமெரிக்கன் மருத்துவ குழு சங்கம் , மருத்துவ வளர்ச்சி , கல்லீரல் நோய் , செயற்கை உளவுத்துறை , மருந்து கண்டுபிடிப்பு , மருத்துவ நிலை ,

Hepion Pharmaceuticals, Inc.: Former Novo Nordisk Executive, Dr. Todd M. Hobbs, Joins Hepion Pharmaceuticals as Chief Medical Officer

(2)
EDISON, NJ / ACCESSWIRE / February 10, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)( Hepion ), a clinical stage biopharmaceutical company focused on Artificial Intelligence ( AI )-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis ( NASH ) and liver disease, today announced the appointment of Todd M. Hobbs, M.D., to the newly created position of Chief Medical Officer ( CMO ), effective February 16, 2021.
In this role, Dr. Hobbs will help lead Hepion s engagement with the U.S. Food and Drug Administration ( FDA ), global and national thought leaders, key policymakers, and professional associations.
Dr. Hobbs joins Hepion from Novo Nordisk Inc., one of the world s leading healthcare companies. His 16 years of progressive experience at Novo Nordisk includes positions ranging from field medical affairs leadership at the start of his corporate career through to his most recent role as North American Chief Medical Officer and Vice ....

University Of Louisville , United States , Stephen Kilmer , Toddm Hobbs , Robert Foster , American Medical Group Association , University Of Louisville School Medicine , Drug Administration , Hepion Pharmaceuticals Inc , Exchange Commission , Hepion Pharmaceuticals , University Of Pennsylvania Wharton School Business , Hepion Pharmaceuticals Investor Relations , Novo Nordisk , Novo Nordisk Inc , Artificial Intelligence , Chief Medical Officer , North American Chief Medical Officer , American Medical Group Association Foundation , Louisville School , Wharton School , Private Securities Litigation Reform Act , Hepion Pharmaceutical , Hepion Pharmaceutical Form , Medi Cal , பல்கலைக்கழகம் ஆஃப் லூயிஸ்வில்லி ,